Aclara BioSciences Inc., of Hayward, Calif., named Bertram Rowland vice president and general counsel.
AeroGen Inc., of Sunnyvale, Calif., elected to its board of directors Jean-Jacques Bienaime, CEO of SangStat Medical Corp.
Affymetrix Inc., of Santa Clara, Calif., appointed Ronald Verdoorn executive vice president, global manufacturing.
Alerge Medical Inc., of San Francisco, appointed Jan Barker vice president of operations. Lawrence Goldberg was retained in a consultative role to act as vice president of marketing and research.
Alexion Pharmaceuticals Inc., of New Haven, Conn., named Nancy Motola vice president, regulatory affairs and quality assurance, and Paula Craft senior director, quality assurance and compliance.
Alpha Therapeutic Corp., of Los Angeles, promoted Shinji Wada to vice president, international operations; Joseph DArco, senior vice president, business development and licensing; and Armand Famiglietti, vice president, strategic planning and project management.
AltaRex Corp., of Waltham, Mass., named Christopher Nicodemus senior vice president, medical and regulatory affairs.
Amarillo Biosciences Inc., of Amarillo, Texas, appointed Kathleen Kelleher chief operating officer and vice president of business development.
Ariad Pharmaceuticals Inc., of Cambridge, Mass., named Laurie Allen senior vice president, corporate development and legal affairs and general counsel.
ArQule Inc., of Medford, Mass., appointed Stephen Hill president and CEO.
AtheroGenics Inc., of Norcross, Ga., named Mark Colonnese vice president of finance and chief financial officer.
Atlantic Pharmaceuticals Inc., of Raleigh, N.C., named as a director Martin Cleary, co-founder, president and CEO of CardioGene Therapeutics.
Atugen Biotechnology GmbH, of Berlin, named Klaus Giese vice president of research.
Aurora Biosciences Corp., of San Diego, promoted Thomas Klopack to senior vice president.
Biogen Inc., of Cambridge, Mass., promoted James Mullen to president and chief operating officer. It also named Burt Adelman vice president, medical research; Michael Booney, vice president, sales and marketing; Joseph Davie, senior vice president, research; Sylvie Gregoire, vice president, regulatory affairs; and Mark Leuchtenberger, vice president, international.
BiQuest Inc., of Houston, appointed Wayne Fritzsche as special advisor to the board of directors.
Caliper Technologies Corp., of Mountain View, Calif., appointed Daniel Kisner president and CEO.
Cardiac Science Inc., of Irvine, Calif., named Michael Gioffredi vice president, sales and marketing, and Barry Klegerman director of sales.
Cell Therapeutics Inc., of Seattle, appointed Edward Kenney chief operating officer.
Cellegy Pharmaceuticals Inc., of South San Francisco, appointed Jiro Hayashi special advisor business development in Japan.
Cerus Corp., of Concord, Calif., named Robert Miller vice president of finance and chief financial officer.
Clinicor Inc., of Austin, Texas, appointed Janice Hutt, D. Patrick Hankey and Ajay Ohir directors of business development.
CombiChem Inc., of San Diego, named Mark Suto vice president, operations ChiroChem.
Copernicus Therapeutics Inc., of Cleveland, named Maureen Costello director, pharmaceutical development.
Cor Therapeutics Inc., of South San Francisco, added Patrick Broderick as senior vice president, general counsel and corporate secretary; Lee Rauch, senior vice president, corporate development; Anne Randolph, vice president, development; and Peter Roddy, vice president, finance.
Cortex Pharmaceuticals Inc., of Irvine, Calif., appointed Robert Allnutt chairman of the board.
CuraGen Corp., of New Haven, Conn., appointed Lloyd Smith to its scientific advisory board. Smith, a Romnes Faculty Fellow and professor of chemistry at the University of Wisconsin-Madison, is credited with developing the first fluorescent-based automated DNA sequencing instrument.